ApoE4 associated with severe COVID-19 outcomes via downregulation of ACE2 and imbalanced RAS pathway

Feng Chen,Yanting Chen,Qiongwei Ke,Yongxiang Wang,Zheng Gong,Xiongjin Chen,Yujie Cai,Shengnan Li,Yuanhong Sun,Xiaoping Peng,Yao Ji,Tianzhen Zhang,Wenxian Wu,Lili Cui,Yan Wang
DOI: https://doi.org/10.1186/s12967-023-03945-7
IF: 8.44
2023-02-10
Journal of Translational Medicine
Abstract:Recent numerous epidemiology and clinical association studies reported that ApoE polymorphism might be associated with the risk and severity of coronavirus disease 2019 (COVID-19), and yielded inconsistent results. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection relies on its spike protein binding to angiotensin-converting enzyme 2 (ACE2) receptor expressed on host cell membranes.
medicine, research & experimental
What problem does this paper attempt to address?